Fungal Infection Testing + Diagnostics for Human Health

Since 2002, MiraVista Diagnostics has been developing and evolving our menu of diagnostic tests for fungal infections. We work with hospital labs, research university labs, government and municipal labs, physician practices, large reference labs and CROs across the country to detect, analyze and monitor a wide range of serious mycology infections that afflict their patients. This includes antigen and antibody detection tests for aspergillus, blastomyces dermatitidis, histoplasma capsulatum, coccidioides, cryptococcus and beta-D-glucan.

Accurate Test Results Lead to Better Patient Outcomes

MiraVista Diagnostics understands the critical role we play in the health care and health science continuum. Because we take that responsibility seriously, we are committed to partnering with clinicians to consistently deliver:

  • Superior clinical standards in testing accuracy and sensitivity
  • Rapid response and test results
  • Dedication to excellent client service and customer satisfaction
  • Direct access to our infectious disease experts
  • Quality assurance across our organization
  • Compliance with regulatory mandates and industry best practices
  • Continuous product and service improvement
Company News

CDC Investigating Histoplasmosis Outbreak Among Boy Scout Campers in Baton Rouge

At least two Boy Scout campers have been diagnosed with histoplasmosis after staying at Camp Avondale in Baton Rouge, Louisiana.

MiraVista to Receive Economic Incentives from IEDC for Expansion Efforts

Indiana Economic Development Corporation Offers economic incentives to MiraVista Diagnostics. This includes $275,000 in tax credits and $50,000 in training grants to hire additional employees and expand its corporate headquarters and diagnostic laboratory in Indianapolis.

MiraVista Diagnostics is Participating in 2018 ID Week in San Francisco

MiraVista Diagnostics is participating in 2018 ID Week in San Francisco on October 3-7, 2018. Visit us at booth #1032. Representatives from MiraVista will be available to discuss our latest mycology research and menu of diagnostic tests for serious fungal…

MiraVista is a Sponsor & Poster Presenter @ 2018 MSGERC Biennial Meeting in Big Sky, Montana

MiraVista Diagnostics is a sponsor and poster presenter at the 2018 Biennial Meeting of the Mycoses Study Group Education and Research Consortium (MSGERC) in Big Sky, Montana on September 25-28, 2018. Poster: Largest Study of Histoplasma Meningitis Debunks Assumptions of…

MiraVista Diagnostics Supports 2018 Fungal Disease Awareness Week

August 13-17 is 2018 Fungal Disease Awareness Week. CDC and partners have organized this week to highlight the importance of recognizing serious fungal diseases early enough in the course of a patient’s illness to provide life-saving treatment. MiraVista Diagnostics supports…

Visit MiraVista at ASM Microbe 2018 in Atlanta

MiraVista Diagnostics is exhibiting at ASM Microbe 2018 in Atlanta on June 7-11, 2018. Please stop by our booth to talk with one of our team members about diagnostic options for serious fungal infections. For more information about ASM Microbe…

  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo